Nature Reviews Clinical Oncology

Vol. 22, Issue 9 Issue 9 2025
11
Articles

Articles in this Issue

Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing

Avi Petroff, Ian F. Tannock, Daniel A. Goldstein Sep 01, 2025 pp. 701-701 10.1038/s41571-025-01063-5

Evolving roles of MET as a therapeutic target in NSCLC and beyond

Jii Bum Lee, Joo Sung Shim, Byoung Chul Cho Sep 01, 2025 pp. 640-666 10.1038/s41571-025-01051-9

The microbiota in radiotherapy-induced cancer immunosurveillance

Jianzhou Chen, Eric Deutsch, Guido Kroemer et al. Sep 01, 2025 pp. 667-679 10.1038/s41571-025-01052-8

EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma

Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro et al. Sep 01, 2025 pp. 680-700 10.1038/s41571-025-01041-x

A new first-line option for advanced-stage anal squamous cell carcinoma

Diana Romero Sep 01, 2025 pp. 623-623 10.1038/s41571-025-01056-4

Role of novel immunotherapy combinations in the management of advanced-stage hepatocellular carcinoma

Josep M. Llovet Sep 01, 2025 pp. 625-626 10.1038/s41571-025-01055-5

Ecological management of the microbiota in patients with cancer

Joao B. Xavier Sep 01, 2025 pp. 627-639 10.1038/s41571-025-01049-3

From ASCO 2025

Diana Romero Sep 01, 2025 pp. 624-624 10.1038/s41571-025-01053-7

Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA

David Killock Sep 01, 2025 pp. 623-623 10.1038/s41571-025-01048-4

Robot-assisted laparoscopic surgery confers improved oncological outcomes

Peter Sidaway Sep 01, 2025 pp. 623-623 10.1038/s41571-025-01050-w

Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring

Neil Carleton, Priscilla F. McAuliffe Sep 01, 2025 pp. 621-622 10.1038/s41571-025-01040-y

All Issues

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page